F/m Emerald Life Sciences Innovation ETF (LFSC): ETF
ETF traded on XNAS under symbol LFSC. Quoted in usd.
F/m Emerald Life Sciences Innovation ETF
-2.32%$41.59
XNAS:LFSCEquity
AUM $115M·YTD --·Yield --
XNAS:LFSC$41.59-2.32%AUM $115MTop Holdings
54.8% of portfolio in top 10 holdings
Performance:
 | LIVN LivaNova PLC | +4.85% | 105.4K | |
 | COGT Cogent Biosciences Inc | -0.64% | 235.5K | |
 | REPL Replimune Group Inc | -11.57% | 620.2K | |
 | CORT Corcept Therapeutics Inc | -23.98% | 69.0K | |
 | TVTX Travere Therapeutics Inc | -16.30% | 140.2K | |
 | GH Guardant Health Inc | -4.10% | 37.7K | |
 | BLLN Billiontoone Inc | -5.81% | 54.1K | |
 | MANE VeraDermics Inc | +19.87% | 37.0K | |
 | UTHR United Therapeutics Corp | +20.04% | 8.0K | |
 | SYRE Spyre Therapeutics Inc | +2.45% | 51.6K | |
 | MIRM Mirum Pharmaceuticals Inc | -10.00% | 49.6K | |
 | CYTK Cytokinetics Inc | -6.96% | 62.7K | |
 | TMDX TransMedics Group Inc | -18.69% | 50.2K | |
 | AXSM Axsome Therapeutics Inc | -25.02% | 23.0K | |
 | ICUI ICU Medical Inc | +2.02% | 20.3K | |
 | SVRA Savara Inc | -15.60% | 677.9K | |
 | TWST Twist Bioscience Corp | -11.72% | 18.6K | |
 | CBLL Ceribell Inc | +14.86% | 92.0K | |
 | TRVI Trevi Therapeutics Inc | -12.79% | 198.1K | |
 | PVLA Palvella Therapeutics Inc | -16.35% | 18.0K | |
 | PRAX Praxis Precision Medicines Inc | -10.34% | 8.3K | |
 | NKTR Nektar Therapeutics | -35.45% | 53.0K | |
 | CRVS Corvus Pharmaceuticals Inc | -16.03% | 172.1K | |
 | DNTH Dianthus Therapeutics Inc | -17.83% | 22.7K | |
 | VRDN Viridian Therapeutics Inc | +4.39% | 77.2K |
Institutional Holders
Holdings Treemap
Country Allocation
| Country | Weight |
|---|---|
| United States | 92.64% |
| United Kingdom | 7.36% |